PROPHYLACTIC OR THERAPEUTIC AGENT FOR TUMORS, PD-L1 INHIBITOR, SCREENING METHOD FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR TUMORS, AND SCREENING METHOD FOR PD-L1 INHIBITOR

This prophylactic or therapeutic agent for tumors contains, as an active ingredient, an inhibitor against the interaction between HLA-G2 and Leukocyte Ig-like receptor B2 (LILRB2). L'invention concerne un agent prophylactique ou thérapeutique anti-tumoral qui contient comme principe actif un in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KUROKI Kimiko, TAKAHASHI Ami, MAENAKA Katsumi
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This prophylactic or therapeutic agent for tumors contains, as an active ingredient, an inhibitor against the interaction between HLA-G2 and Leukocyte Ig-like receptor B2 (LILRB2). L'invention concerne un agent prophylactique ou thérapeutique anti-tumoral qui contient comme principe actif un inhibiteur de l'interaction entre le HLA-G2 et le récepteur LILRB2 (LILRB2). 腫瘍予防又は治療剤は、ＨＬＡ－Ｇ２と白血球Ｉｇ様受容体Ｂ２（ＬＩＬＲＢ２）との相互作用阻害剤を有効成分とする。